School of Medicine
Showing 1-8 of 8 Results
-
Latha Palaniappan, MD, MS
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.
-
Victoria Parikh, MD
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.
-
Alexander C. Perino
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioAlexander C. Perino, MD is a cardiac electrophysiologist at Stanford Health Care whose primary focus is providing procedural care for patients with heart rhythm disorders. He performs a wide range of ablation and cardiac device implantation procedures, utilizing cutting-edge techniques and technologies to deliver high-quality, patient-centered care.
Dr. Perino serves as the Director of the Electrophysiology Laboratory at Stanford Health Care, where he leads efforts to enhance procedural quality, safety, and patient outcomes across the electrophysiology program. He is also the principal investigator for numerous clinical trials, working to ensure that patients have the opportunity to participate in research and contribute to scientific advancement—without compromising the quality of their care.
In addition, Dr. Perino is the Medical Informatics Director for the Division of Cardiovascular Medicine at Stanford Health Care. In this role, he oversees initiatives aimed at improving the quality and safety of cardiovascular care, while optimizing the electronic health record to better support patients and clinicians alike. -
Jena Pizula, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Pizula is a quadruple board-certified, fellowship-trained cardiologist with Stanford Health Care Cardiovascular Health. She is also a clinical assistant professor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine. She completed a fellowship in cardiovascular medicine at the University of Southern California (USC) Keck School of Medicine.
Dr. Pizula specializes in cardio-obstetrics. She works with women before, during, and after pregnancy to determine their risk of heart-related pregnancy complications and improve their cardiovascular health. She has experience managing complex cardiovascular conditions, including congenital heart disease, arrhythmias, coronary artery disease, valvular disease, and cardiomyopathy. Dr. Pizula develops a customized care plan for each patient she treats. As a leader in cardio-obstetrics, she’s at the forefront of the latest advances in women’s cardiovascular care.
Her research interests include the intersection of cardiovascular disease and pregnancy. She focuses on how pre-existing conditions like congenital heart disease, cardiomyopathy, or hypertension affect pregnancy. She has also explored how physiological changes during pregnancy affect existing heart disease and long-term cardiovascular risk. She uses her unique dual background in internal medicine and pediatrics to study how adult manifestations of cardiovascular disease impact pregnancy outcomes.
Dr. Pizula is active in teaching medical students, internal medicine and obstetrical residents, and cardiology fellows. She teaches them strategies to improve how they assess and manage risk and deliver postpartum care to people with high-risk cardiac pregnancies. Dr. Pizula is the director of the Finishing School for Future Cardiologists for the California chapter of the American College of Cardiology, which offers leadership development to cardiology fellows.
Dr. Pizula’s research has been published in the Journal of the American Heart Association, Journal of the American College of Cardiology, The Journal of Heart and Lung Transplantation, Journal of General Internal Medicine, and Pediatrics. She has authored three book chapters on cardio-obstetrics and global emergency medicine.
Dr. Pizula has presented her research at conferences in the United States and internationally. As an expert in cardiovascular disease and pregnancy, she is frequently invited to speak to cardiologists, obstetricians, and anesthesiologists at the International Congress on Cardiac Problems in Pregnancy. She currently serves as a reviewer for the European Journal of Heart Failure and Heart Failure Reviews.
Dr. Pizula is a member of the American College of Cardiology, Stanford Medicine Cardiovascular Institute, and Stanford Medicine Maternal & Child Health Research Institute. -
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Krishna Pundi
Clinical Instructor, Medicine - Cardiovascular Medicine
BioKrishna Pundi, MD is a cardiac electrophysiologist and health services and outcomes researcher with a clinical interest in the management of ventricular arrhythmias and atrial fibrillation.
Dr. Pundi leads a multidisciplinary research program to study (1) clinical and arrhythmia-specific factors that predict cardiovascular risk for ventricular arrhythmias, (2) the interplay of frailty and obesity with atrial fibrillation outcomes, and (3) the role of digital health and wearables in arrhythmia care. He has led grant-funded research through the NIH, FDA, and ACC and collaborations with large device and quality databases including AHA’s Get With the Guidelines. He has a special interest in innovation and regulatory science, having organized national Think Tanks of patients, investigators, and FDA to define the scientific and clinical use of wearable monitors. Dr. Pundi holds leadership roles through the American College of Cardiology, Heart Rhythm Society, Cardiovascular Sciences Research Consortium, and HRX - an innovation-focused meeting of clinicians, researcher, and industry.
